Common Oncogenic Driver Mutations and PD-L1 Expression in Non-Small Cell Lung Cancer of Smokers and Never Smokers

被引：0
|
作者：
Liam, C. K. [1 ]
Yew, C. Y. [1 ]
Pang, Y. K. [1 ]
Wong, C. K. [1 ]
Poh, M. E. [1 ]
Tan, J. L. [1 ]
Soo, C. I. [1 ]
Loh, T. C. [1 ]
Chin, K. K. [1 ]
Munusamy, V. [1 ]
Ibrahim, N. H. [1 ]
机构：
[1] Univ Malaya, Dept Med, Kuala Lumpur, Malaysia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
EGFR mutations; PD-L1; expression; smoking status;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P57.09
引用
收藏
页码：S1141 / S1142
页数：2
相关论文
共 50 条
  • [21] Effect on Non-Small Cell Lung Cancer After Combination of Driver Gene Mutations and Anti-PD-1/PD-L1 Immunotherapy as Well as Chemotherapy
    Huang, Zhengming
    Yu, Long
    Chen, Weisong
    Zhu, Dan
    Chen, Hui
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2024, 53 (08) : 1754 - 1768
  • [22] PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations
    Scheel, Andreas H.
    Ansen, Sascha
    Schultheis, Anne M.
    Scheffler, Matthias
    Fischer, Rieke N.
    Michels, Sebastian
    Hellmich, Martin
    George, Julie
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry
    Timens, Wim
    Perner, Sven
    von Bergwelt-Baildon, Michael
    Buettner, Reinhard
    Wolf, Juergen
    ONCOIMMUNOLOGY, 2016, 5 (05):
  • [23] Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer
    Lastwika, Kristin J.
    Wilson, Willie, III
    Li, Qing Kay
    Norris, Jeffrey
    Xu, Haiying
    Ghazarian, Sharon R.
    Kitagawa, Hiroshi
    Kawabata, Shigeru
    Taube, Janis M.
    Yao, Sheng
    Liu, Linda N.
    Gills, Joell J.
    Dennis, Phillip A.
    CANCER RESEARCH, 2016, 76 (02) : 227 - 238
  • [24] Spatial heterogeneity of PD-L1 expression and the risk for misclassification of PD-L1 immunohistochemistry in non-small cell lung cancer
    Dori, Shani Ben
    Aizic, Asaf
    Sabo, Edmond
    Hershkovitz, Dov
    LUNG CANCER, 2020, 147 : 91 - 98
  • [25] The association of BTLA gene polymorphisms with non-small lung cancer risk in smokers and never-smokers
    Andrzejczak, Anna
    Partyka, Anna
    Wisniewski, Andrzej
    Porebska, Irena
    Pawelczyk, Konrad
    Ptaszkowski, Kuba
    Kusnierczyk, Piotr
    Jasek, Monika
    Karabon, Lidia
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [26] The Relationship of TILs and PD-L1 Expression in NSCLC Adenocarcinoma in Little to Non-Smokers with Driver Mutations and Outcome Parameters
    Mignon, Sacha
    Willard-Gallo, Karen
    Van den Eynden, Gert
    Salgado, Roberto
    Waelput, Wim
    Decoster, Lore
    Marien, Koen
    Vansteenkiste, Johan
    Teugels, Erik
    De Greve, Jacques
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1331 - S1331
  • [27] PD-L1 Expression in Non-Small Cell Lung Cancer: Data from a Referral Center in Spain
    Saez de Gordoa, Karmele
    Lopez, Ingrid
    Marginet, Marta
    Coloma, Berta
    Frigola, Gerard
    Vega, Naiara
    Martinez, Daniel
    Teixido, Cristina
    DIAGNOSTICS, 2021, 11 (08)
  • [28] PD-1 and PD-L1 as immunotherapy targets and biomarkers in non-small cell lung cancer
    Tsoukalas, Nikolaos
    Kiakou, Maria
    Tsapakidis, Konstantinos
    Tolia, Maria
    Aravantinou-Fatorou, Eleni
    Baxevanos, Panagiotis
    Kyrgias, Georgios
    Theocharis, Stamatios
    JOURNAL OF BUON, 2019, 24 (03): : 883 - 888
  • [29] Durvalumab for the treatment of PD-L1 non-small cell lung cancer
    Naito, Tomoyuki
    Shiraishi, Hideaki
    Fujiwara, Yutaka
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2021, 6 (02): : 95 - 105
  • [30] PD-L1 Expression, EGFR Mutations and ALK Expression in Non-Small Cell Lung Cancer (NSCLC) Patients from Brazil
    Alves Da Silva, A. V.
    Tavora, F.
    Martins Neto, F.
    Oliveira, A. C. D. S.
    Alves, M.
    Carneiro, B.
    Lima, A. M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1020 - S1020
12345